ArticleScientific reports2026
Probiotic Bacillus licheniformis competitively establishes and enhances production efficiency, immune responsiveness, and protection against Aeromonas hydrophila O:18 in Cirrhinus mrigala (Ham.).
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Invisible Balance: How Prebiotics and Probiotics Can Support Fish Health and Development.Life (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of probiotics is increasingly becoming a strategic tool in aquaculture production systems to mitigate the impacts of antimicrobial resistance. The effects of dietary Bacillus licheniformis on the immune response and disease resistance of Cirrhinus mrigala were investigated following a 30-day growth trial. One hundred eighty fingerlings (10 ± 2 g) were randomly assigned to five groups (three replicates each) and fed either a control diet or diets supplemented with B. licheniformis at 1.0 × 10⁶ cfu g⁻
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.